cas 1571103-88-2|| where to buy 12,15-Dioxa-2,7,9-triazaheptadecanamide, 17-amino-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]-8-oxo-, hydrochloride (1:2)

Nombre del producto:12,15-Dioxa-2,7,9-triazaheptadecanamide, 17-amino-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]-8-oxo-, hydrochloride (1:2)

IUPAC Name:3-{2-[2-(2-aminoethoxy)ethoxy]ethyl}-1-{4-[({2-[2-(2-aminoethoxy)ethoxy]ethyl}carbamoyl)amino]butyl}urea dihydrochloride

: CAS：1571103-88-2; Fórmula molecular：C18H42Cl2N6O6; Pureza：95%+

Unidad de embalaje	Stock disponible	Precio($)
CM454250-100mg	in stock	ƴţ
CM454250-250mg	in stock	ţţǸ
CM454250-1g	in stock	řŽħ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1571103-88-2 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1571103-88-2; Fórmula molecular:C18H42Cl2N6O6; Punto de fusión:-; Código de sonrisas:Cl.Cl.NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCN; Densidad:

: Número de catálogo:CM454250; Peso molecular:509.47; Punto de ebullición:; Nº Mdl:MFCD29035188; Almacenamiento:

: Tenapanor; FDA has approved XPHOZAH (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

XPHOZAH, with its unique blocking mechanism of action, acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3), reducing phosphate absorption through the paracellular pathway, the primary pathway of phosphate absorption.